Study of Karenitecin (BNP1350) in Patients With Brain Tumors
The purpose of this study is to evaluate safety and efficacy ofKarenitecin (BNP1350) as a treatment of adults with brain tumors.
Brain Neoplasms|Malignant Neoplasms, Brain|Brain Tumors
DRUG: Karenitecin (BNP1350)
Objective Tumor Response Rate, Randomization to end of treatment
Overall Survival, Randomization to date of death due to any cause|Overall Safety, Randomization to end of study participation
The purpose of this study is to evaluate safety and efficacy ofKarenitecin (BNP1350) as a treatment of adults with brain tumors.